PAPER El-Azab MF, Baldowski BR, Mysona BA, Shanab AY, Mohamed IN, Abdelsaid MA, Matragoon S, Bollinger KE, Saul A, El-Remessy AB
Br J Pharmacol. 2014 Mar;171(5):1299-313. PubMed: 24283717
PAPER Vantaggiato C, Clementi E, Bassi MT
Autophagy. 2014 Feb;10(2):374-5. Epub 2013 Nov 26 PubMed: 24284334
PAPER Han J, Pollak J, Yang T, Siddiqui MR, Doyle KP, Taravosh-Lahn K, Cekanaviciute E, Han A, Goodman JZ, Jones B, Jing D, Massa SM, Longo FM, Buckwalter MS
Stroke. 2012 Jul;43(7):1918-24. PubMed: 22535263
PAPER Simmons DA, Belichenko NP, Yang T, Condon C, Monbureau M, Shamloo M, Jing D, Massa SM, Longo FM
J Neurosci. 2013 Nov 27;33(48):18712-27. PubMed: 24285878
CONFERENCE COVERAGE SERIES Are New Cognitive Tests Ready For Preclinical Trials? Do Tau Tracers Track Cognitive Decline in Disease? Growth Factor Therapy: Safe in Phase 1, Awaiting Efficacy Data Clinical Trials on Alzheimer’s Disease 2013
CONFERENCE COVERAGE 2013-11-29 Conference Coverage The later stages of Alzheimer’s disease are characterized by massive loss of neurons, and researchers are looking at ways to boost molecular support systems in the hope of preserving some of those cells. At the Sixth Clinical Trials Co
PAPER Lagarde J, Valabrègue R, Corvol JC, Pineau F, Le Ber I, Vidailhet M, Dubois B, Levy R
PLoS One. 2013;8(11):e80353. Epub 2013 Nov 20 PubMed: 24278277
PAPER Newman AJ, Selkoe D, Dettmer U
PLoS One. 2013;8(11):e81314. Epub 2013 Nov 20 PubMed: 24278419